UPDATED WITH VIDEO: FDA OKs Keytruda, the First PD-1 Blocker for Advanced Melanoma

The FDA granted accelerated approval to Merck & Co’s Keytruda (pembrolizumab) for patients with advanced or unresectable melanoma who are no longer responding to other drugs. Keytruda is the sixth new melanoma treatment approved since 2011.